Skip to main content
. 2015 Jan 27;59(2):979–987. doi: 10.1128/AAC.04226-14

TABLE 3.

Selection of resistant variants in NS5A by ombitasvir in genotype 2 to 6 subgenomic chimeric replicon cell lines

Genotype Variant Prevalence in replicon assaysa Mean EC50 (pM) ± SDb Fold resistance
2ac Wild type 1.3 ± 0.1
T24A 8/15 50 ± 6.9 38
T24A (L31) 20 ± 0.37 15
F28S 4/15 4,710d
2bc Wild type 0.71 ± 0.37
L28F 1/24 33 ± 6.1 47
L28F (M31) 176 ± 30 247
L31V 8/24 361 ± 70 511
Y93H 13/24 NA
3a wt 4.4 ± 2.4
M28T 3/24 2,934 ± 1,618 659
L31F 3/24 28d
Y93H 14/24 29,940 ± 368 6,728
4a Wild type 0.35 ± 0.07
L28V 21/21 8.0 ± 2.8 23
5a Wild type 0.91 ± 0.34
L28I 6/23 72 ± 25 79
L31V 12/23 220 ± 105 243
L31F 6/23 263 ± 117 289
6a Wild type 82 ± 58
L31V 4/24 5,572 ± 734 68
T58N 4/24 8,354 ± 1,248 101
T58A 8/24 1,452 ± 599 18
T58S 6/24 1,504 ± 319 18
a

Number of times this variant was found/total number of colonies analyzed.

b

EC50 of ombitasvir in replicon containing the variant in NS5A determined using transient luciferase assay. NA, not available due to low replication efficiency of the variant.

c

The genotype 2a replicon cell line contains Met at position 31; the genotype 2b replicon cell line contains Leu at position 31.

d

F28S in GT 2a and L31F in GT 3a replicated poorly in a transient assay; therefore, the EC50 and fold resistance were evaluated in a stable chimeric replicon cell line.